Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia

Laboratory Investigation

Volumn 74, Issue 1, 1996, Pages 253-258

  Kanfer, Alain ^a,b,c   Bruch, Jean Frédéric ^d   Nguyen, Geneviève ^b   He, Ci Jiang ^b   Delarue, Françoise ^b   Flahault, Antoine ^c   Nessmann, Catherine ^d   Uzan, Serge ^e  

^a Serv de Pediat Gen   (France)

^b INSERM   (France)

^c HÔPITAL TENON   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e HÔpital Bichat   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FIBRIN DEPOSITION; HEMOSTASIS; HUMAN; MATERNAL HYPERTENSION; MORPHOMETRICS; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL;

ADULT; FEMALE; FIBRIN; FIBRINOLYSIS; HEMOSTASIS; HUMANS; HYPERTENSION; PLACENTA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; THROMBOMODULIN;

EID: 0030042576     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. De Boer K, Cate JWT, Sturk A, Borm JJJ, and Treffers PE (1989). Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 160:95-100.
2. Douglas JT, Shah M, Lowe GDO, Belch JJF, Forbes CD, and Prentice CRM (1982). Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hpertension. Thromb Haemost 47:54-55.
3. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espana S, Loskutoff DJ, and Schleef RR (1994). Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 84:143-150.
4. Fox H and Path MC (1968). Fibrinoid necrosis of placental villi. J Obstet Gynaecol Br Commonw 75:448-452.
5. Fox H and Path MC (1967). Perivillous fibrin deposition in the human placenta. Am J Obstet Gynecol 98:245-251.
6. Frank HG, Malekzadeh F, Crescimanno C, Castellucci M, Desoye G, and Kaufmann P (1993). Human placental fibrinoid shows a heterogenous distribution of fibrin and extracellular matrix components (abstract). Placenta 14:23.
7. Freyssinet JM, Brami B, Gauchy J, and Cazenave JP (1986). Coextraction of thrombomodulin and tissue factor from human placenta: Effects of concanavalin A and phospholipid environment on activity. Thromb Haemost 55:112-118.
8. He CJ, Rondeau E, Medcalf RL, Lacave R, Schleuning WD, and Sraer JD (1991). Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J Cell Physiol 146:131-140.
9. Labarrere CA and Faulk WP (1992). Microvascular perturbations in human allografts: analogies in preeclamptic placentae. Am J Reprod Immunol 27:109-116.
10. McKay DC (1981). Chronic intravascular coagulation in normal pregnancy and preeclampsia. Contrib Nephrol 25:108-119.
11. Nelson M, Crouch EC, Curran EM, and Farmer DR (1990). Trophoblast interaction with fibrin matrix. Epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placenta. Am J Pathol 136:855-865.
12. Redman CWG, Bonnar J, and Beilin L (1978). Early platelet consumption in pre-eclampsia. Br Med J 1:467-469.
13. Roberts JM and Redman CWG (1993). Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 341:1447-1454.
14. Sakata Y, Curriden S, Lawrence D, Griffin JH, and Loskutoff DJ (1985). Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 82:1121-1125.
15. Sutcliffe RG, Davies M, Hunter JB, Waters JJ, and Parry JE (1982). The protein composition of the fibrinoid material at the human uteroplacental interface. Placenta 3:297-308.
16. The Birmingham Eclampsia Study Group (1971). Intravascular coagulation and abnormal lung-scans in pre-eclampsia and eclampsia. Lancet 2:889-891.
17. Trofatter KF, Howell ML, Greenberg CS, and Hage ML (1989). Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia. Obstet Gynecol 73:435-439.
18. Van Hinsberg VWM, Bertina RM, Van Wijngaarden A, Van Tilburg NH, Emeis JJ, and Haverkate F (1985). Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 65: 444-451.
19. VanMourik JA, Lawrence DA, and Loskutoff DJ (1984). Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by bovine endothelial cells. J Biol Chem 259: 14914-14921.
20. Walsh SW (1985). Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 152:335-340.
21. Yoshimura T, Yamashita J, Ito M, Matsui K, and Maeyama M (1985). Placental plasminogen activator activity in preeclampsia. Int J Gynaecol Obstet 23:311-314.